Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
NCT03975231
- Conditions
- BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Carcinoma, +5 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Univ of Texas-M.D. Anderson Cancer Center Houston, Texas, United States
Recruiting
[177Lu]Lu-AKIR001 First-in-human Study
NCT06639191
- Conditions
- Bronchial Neoplasms, Cancer Head and Neck, Carcinoma, +31 more
- Locations
-
- Karolinska University hospital Stockholm, Stockholm County, Sweden
NCT01236547
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
NCT00625846
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +29 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Colorado Hospital Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Active, Not Recruiting
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
NCT03449108
- Conditions
- Adnexal Diseases, Bone Diseases, Bone Neoplasms, +49 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04759911
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- University of Michigan Health Systems Ann Arbor, Michigan, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
NCT04675710
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- Stanford School of Medicine Stanford, California, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States
- Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States